301 related articles for article (PubMed ID: 31288128)
1. Boron in drug design: Recent advances in the development of new therapeutic agents.
Fernandes GFS; Denny WA; Dos Santos JL
Eur J Med Chem; 2019 Oct; 179():791-804. PubMed ID: 31288128
[TBL] [Abstract][Full Text] [Related]
2. Utility of boron in dermatology.
Jackson DG; Cardwell LA; Oussedik E; Feldman SR
J Dermatolog Treat; 2020 Feb; 31(1):2-12. PubMed ID: 28789577
[No Abstract] [Full Text] [Related]
3. Crisaborole (Eucrisa) for Mild to Moderate Atopic Dermatitis.
Castelli G; Schaffer M
Am Fam Physician; 2018 Sep; 98(6):379-380. PubMed ID: 30215912
[No Abstract] [Full Text] [Related]
4. Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis.
Woo TE; Kuzel P
Skin Therapy Lett; 2019 Mar; 24(2):4-6. PubMed ID: 30970204
[TBL] [Abstract][Full Text] [Related]
5. Potential role of tavaborole for the treatment of onychomycosis.
Gupta AK; Daigle D
Future Microbiol; 2014; 9(11):1243-50. PubMed ID: 25437186
[TBL] [Abstract][Full Text] [Related]
6. Boron chemicals in diagnosis and therapeutics.
Das BC; Thapa P; Karki R; Schinke C; Das S; Kambhampati S; Banerjee SK; Van Veldhuizen P; Verma A; Weiss LM; Evans T
Future Med Chem; 2013 Apr; 5(6):653-76. PubMed ID: 23617429
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on tavaborole for the treatment of onychomycosis.
Jinna S; Finch J
Drug Des Devel Ther; 2015; 9():6185-90. PubMed ID: 26640371
[TBL] [Abstract][Full Text] [Related]
8. Crisaborole 2% Ointment (Eucrisa
Gupta AK; Versteeg SG; Abramovits W; Vincent KD
Skinmed; 2017; 15(5):377-380. PubMed ID: 29139367
[No Abstract] [Full Text] [Related]
9. Crisaborole: A new and effective nonsteroidal topical drug for atopic dermatitis.
Kailas A
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834023
[No Abstract] [Full Text] [Related]
10. Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
Gupta G; Foley KA; Gupta AK
Skin Therapy Lett; 2015 Nov; 20(6):6-9. PubMed ID: 27224843
[TBL] [Abstract][Full Text] [Related]
11. Tavaborole: first global approval.
Markham A
Drugs; 2014 Sep; 74(13):1555-8. PubMed ID: 25118637
[TBL] [Abstract][Full Text] [Related]
12. Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis.
Paton DM
Drugs Today (Barc); 2017 Apr; 53(4):239-245. PubMed ID: 28492291
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.
Baker SJ; Zhang YK; Akama T; Lau A; Zhou H; Hernandez V; Mao W; Alley MR; Sanders V; Plattner JJ
J Med Chem; 2006 Jul; 49(15):4447-50. PubMed ID: 16854048
[TBL] [Abstract][Full Text] [Related]
14. Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis.
Riahi A; Lam JM
Skin Therapy Lett; 2021 Jan; 26(1):1-4. PubMed ID: 33539061
[TBL] [Abstract][Full Text] [Related]
15. Tavaborole 5% solution for onychomycosis.
Gupta AK; Daigle D; Abramovits W
Skinmed; 2015; 13(1):55-8. PubMed ID: 25842473
[No Abstract] [Full Text] [Related]
16. Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review.
Kahn JS; Grossman-Kranseler JS; Zancanaro P; Griffiths D; Dumont N; Rosmarin D
Dermatitis; 2021 Nov-Dec 01; 32(6):e141-e143. PubMed ID: 34570730
[No Abstract] [Full Text] [Related]
17. Tavaborole - a treatment for onychomycosis of the toenails.
Gupta AK; Versteeg SG
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
[TBL] [Abstract][Full Text] [Related]
18. Crisaborole, Dupilumab, and Sarilumab.
Hussar DA; Lee YF
J Am Pharm Assoc (2003); 2017; 57(5):640-643. PubMed ID: 28882252
[No Abstract] [Full Text] [Related]
19. Tavaborole, a Novel Boron-Containing Small Molecule Pharmaceutical Agent for Topical Treatment of Onychomycosis: II. Prenatal and Postnatal Developmental Toxicity and Maternal Function Study.
Ciaravino V; Coronado D; Lanphear C; Hoberman A; Chanda S
Int J Toxicol; 2016 Sep; 35(5):543-57. PubMed ID: 27138050
[TBL] [Abstract][Full Text] [Related]
20. Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.
Gupta AK; Daigle D
Expert Rev Anti Infect Ther; 2014 Jul; 12(7):735-42. PubMed ID: 24894552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
